Jane Royalty

Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate

Jill C. Chappell, P. Kellie Turner, Y. Anne Pak et al. · Clinical Pharmacology & Therapeutics · 2018 · 113 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects

Stephen L. Lowe, Conrad J. Wong, Jennifer Witcher et al. · The Journal of Clinical Pharmacology · 2014 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +14

Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects

Jules I. Schwartz, Aimée Dallob, Patrick Larson et al. · The Journal of Clinical Pharmacology · 2008 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +12

Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long‐acting α‐MSH analog in healthy overweight and obese subjects

Jane Royalty, Gitte Konradsen, Ole Eskerod et al. · The Journal of Clinical Pharmacology · 2013 · 40 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Abstract CT153: Pharmacokinetic drug interactions between abemaciclib and CYP3A inducers and inhibitors

Palaniappan Kulanthaivel, Daruka Mahadevan, P. Kellie Turner et al. · Cancer Research · 2016 · 21 citations

Medicine, Pharmacokinetics, Pharmacology +14